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Abstract: This manuscript reviews the possibilities offered by 2,5-dimethylfuran-protected 
maleimides. Suitably derivatized building blocks incorporating the exo Diels-Alder 
cycloadduct can be introduced at any position of oligonucleotides, peptide nucleic acids, 
peptides and peptoids, making use of standard solid-phase procedures. Maleimide 
deprotection takes place upon heating, which can be followed by either Michael-type or 
Diels-Alder click conjugation reactions. However, the one-pot procedure in which 
maleimide deprotection and conjugation are simultaneously carried out provides the target 
conjugate more quickly and, more importantly, in better yield. This procedure is 
compatible with conjugates involving oligonucleotides, peptides and peptide nucleic acids. 
A variety of cyclic peptides and oligonucleotides can be obtained from peptide and 
oligonucleotide precursors incorporating protected maleimides and thiols. 
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1. Introduction. Maleimide-Involving Click Conjugation Reactions with Oligonucleotides  
and Polyamides 
The Michael-type addition of thiols to electron deficient carbon-carbon double bonds is one of the 
oldest click reactions [1]. It takes place quickly and in high yield, does not generate byproducts, and 
can be carried out in water. When applied to bioconjugations, maleimides are the electrophiles most 
commonly used (Scheme 1A). The maleimide-thiol conjugation chemistry has found application in the 
derivatization of all kinds of biomolecules, and in particular in the synthesis of the two antibody-drug 
conjugates approved by the FDA and presently in clinical use [2]. 
More recently, conjugates have also been prepared by exploiting the Diels-Alder reaction between 
maleimides and conjugated dienes (Scheme 1B). This cycloaddition is another modular reaction that 
can link two different compounds in water without producing side products; although, it does not 
proceed as rapidly as the thiol-maleimide reaction. 
 
Scheme 1. Reaction of maleimides with thiols (A) or conjugated dienes (B) provides 
conjugates. The two differently colored triangles represent either two different 
biomolecules or one biomolecule and another compound, such as a fluorophore, a  
spin-label or a metal complex.  
With the exception of thiols that may be present in peptides and proteins, none of the functional 
groups required for the Michael-type and Diels-Alder conjugation reactions exist in biomolecules.  
This is both an advantage and a disadvantage. An advantage because it ensures regioselectivity, in 
other words, it allows the click conjugation reaction to provide a chemically defined conjugate instead 
of a mixture of products. The disadvantage is that the conjugate components must be modified to 
introduce the additional functional group required for conjugation. 
In regards to derivatization with maleimides, they are most often attached to biomolecules making 
use of bifunctional compounds that incorporate the maleimide moiety and a carboxyl group (or an 
active ester), of which the latter is expected to form an amide bond with amino group(s) on the 
biomolecule (peptide, protein). Therefore, molecules lacking or having poorly reactive amines require 
an additional pre-derivatization step. This is the case of oligonucleotides. 
Oligonucleotides are normally prepared by solid-phase synthesis, and can be appended with 
alkylamines while still anchored to the solid support. Yet, the bifunctional maleimide-acid cannot be 
appended to the chain at this stage because maleimides do not withstand the treatment with 
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concentrated aqueous ammonia that removes standard protecting groups and cleaves the 
oligonucleotide-resin linkage, even at room temperature. In addition to Michael-type addition of 
ammonia to the activated double bond, the imide can undergo base-promoted hydrolysis (Scheme 2A). 
Derivatization of oligonucleotides with maleimides can be and has been done in solution by reacting a 
maleimide-acid with an amino-derivatized, fully deprotected oligonucleotide (Scheme 2B) [3–6]. This 
reaction is rather regioselective because the exocyclic amines on the nucleobases are poor 
nucleophiles, but reproducibly good yields are difficult to achieve. 
 
Scheme 2. (A) Imide hydrolysis taking place upon treatment with ammonia of solid-phase 
assembled maleimido-oligonucleotides. (B) Most common methodology used for the 
attachment of maleimides to oligonucleotides in solution. 
We reasoned that a simple solution to this problem might be protecting the maleimide moiety 
(Scheme 3), so that the ammonia treatment provided the oligonucleotide chain derivatized with the 
protected maleimide. The protecting group obviously had to be removable under conditions not 
degrading the oligonucleotide chain. 
 
Scheme 3. General scheme for the solid-phase synthesis of maleimido-oligonucleotides  
and conjugates. 
2. Development of a Maleimide Protection Strategy Allowing Maleimido-Oligonucleotides to Be 
On-Resin Assembled 
2.1. Identification of a Maleimide Protecting Group and Proof of Principle Experiments 
Maleimides can be protected by reaction with dienes, which provides the corresponding 
cycloadduct [7,8]. Since the cycloadducts that can be reversed more easily are those involving furans, 
we decided to evaluate three different furans. To assess their suitability as maleimide protecting groups, 
furan, 2-methylfuran and 2,5-dimethylfuran were reacted with maleimidopropanoic acid, and the 
corresponding cycloadducts (Scheme 4) were heated to recover the unprotected maleimide-containing 
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acid. In agreement with described results [9], the 2,5-dimethyl cycloadduct allowed for the  
reverse Diels-Alder reaction under milder conditions. As a result, 2,5-dimethylfuran-protected  
3-maleimidopropanoic acid was used in the first proof of principle assays [10]. 
 
Scheme 4. Derivatives of 3-maleimidopropanoic acid synthesized and tested to assess the 
extent of maleimide deprotection (retro-Diels-Alder reaction) upon heating under the  
same conditions. 
2,5-Dimethylfuran-protected 3-maleimidopropanoic acid was prepared carrying out the reaction 
between 2,5-dimethylfuran and 3-maleimidopropanoic acid either in CH2Cl2 overnight at room 
temperature, or in acetonitrile for 6 h at 60 °C. The two batches were used to couple the  
maleimide-protected acid to amino-derivatized dT10-resin (Scheme 5). To our initial surprise, after 
ammonia deprotection at room temperature, the HPLC traces of the two crudes showed the same main 
peaks (and products, as assessed by MALDI-TOF MS) but in different ratios (see Scheme 5). Careful 
inspection allowed a correlation between the ratios of exo adduct and target compound, which 
indicated that the endo adduct was not stable to the ammonia deprotection conditions and thus not 
appropriate for maleimide protection (even though it undergoes the retro-Diels-Alder reaction more 
easily) [11]. 
 
Scheme 5. First experiments carried out with batches of 2,5-dimethylfuran-protected  
3-maleimidopropanoic acid containing different exo/endo ratios showed a very good 
correlation between target compound and percentage of exo adduct in the starting material. 
TLC Analysis clearly indicated that separation of the exo and endo isomers of  
2,5-dimethylfuran-protected 3-maleimidopropanoic acid by column chromatography would be neither 
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easy nor high yielding. However, we soon realized that the fact that one cycloadduct was not stable to 
ammonia could be advantageously exploited to separate the two cycloadducts (Scheme 6). Thus, the 
batch containing the exo-rich mixture of cycloadducts was treated with concentrated aqueous ammonia 
overnight at room temperature, and this was followed by evaporation of ammonia under reduced 
pressure, addition of trifluoroacetic acid (or aqueous HCl, see reference [10]) and extraction of the 
resulting aqueous solution with dichloromethane. Dichloromethane removal under reduced pressure 
usually provided pure exo adduct, as assessed by 1H-NMR. In case a mixture still containing endo 
adduct is obtained (generally less than 5%–10%), in particular when carrying out the separation 
process at the gram scale, we repeat the process (once, or even twice, if required) until complete 
purification is achieved. The desired product is always recovered in very high yield (Scheme 6). 
 
Scheme 6. The two 2,5-dimethylfuran-protected 3-maleimidopropanoic acid isomers can 
be easily separated by taking advantage of the stability of the exo cycloadduct in aqueous  
basic conditions. 
We are only aware of one report in which the endo cycloadduct is said to be hydrolyzed in basic 
conditions more quickly than its exo counterpart [12], and to our knowledge no explanation has been 
ever provided for this behavior. 
Pure exo 2,5-dimethylfuran-protected 3-maleimidopropanoic acid was then coupled to  
amino-derivatized dT10-resin (Scheme 7). HPLC analysis of the crude after ammonia treatment at 
room temperature showed that the target (protected maleimide)-dT10 had been obtained, with no 
product resulting from hydrolysis of the succinimide. 
 
Scheme 7. Proof of principle experiments showing that protected-maleimide-dT10 can  
be obtained with no side products from the exo isomer of 2,5-dimethylfuran-protected  
3-maleimidopropanoic acid, and the maleimide subsequently deprotected by carrying out a 
reverse Diels-Alder reaction. 
To deprotect the maleimide, a 1:1 (v/v) MeOH/H2O solution of (protected maleimido)-dT10 was 
heated in a MW oven for 60 min at 90 °C. Deprotection was not quantitative, but the crude was very 
clean. In subsequent experiments the reaction time has always been prolonged to 90 min (see Scheme 9), 
with quantitative or nearly quantitative maleimide deprotection yields (Section 2.2). It was also found 
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that oligonucleotide concentration is an important parameter, and that the homogeneity of the crude 
decreases if this concentration is above 25–50 μM. 
2.2. Experiments Broadening the Scope of Applications of the Method in the Field of  
Oligonucleotide Conjugates 
After this successful preliminary result, the following issues remained to be addressed:  
(i) synthesizing a (protected maleimido)-phosphoramidite enabling to attach the protected maleimide 
moiety to the 5' end of the resin-linked oligonucleotide, under the same conditions as nucleoside 
building blocks and with no need for additional derivatization (that is without requiring incorporation 
of an amine group); (ii) preparing derivatives allowing for incorporation of the protected maleimide 
either at the 3' end or at internal positions; (iii) confirming the compatibility of MW-promoted 
maleimide deprotection conditions with any oligonucleotide sequence, and identifying deprotection 
conditions not requiring a MW oven (which is a fairly common equipment in chemistry but maybe not 
in chemical biology laboratories); (iv) verifying that a fully reactive maleimide is obtained after the 
deprotection step, yielding the target conjugate; and (v) assessing the stability of (protected maleimido)- 
and maleimido-oligonucleotides. 
The phosphoramidite enabling 5' derivatization with a protected maleimide was prepared from  
N-(2-hydroxyethyl)maleimide, which was reacted with 2,5-dimethylfuran, treated with ammonia as 
explained above to obtain the pure exo adduct, and phosphitylated (compound I, Scheme 8) [10].  
This phosphoramidite derivative is now commercially available from Glen Research Co. 
 
Scheme 8. Structures of the phosphoramidite (I and II) and solid support (III) building 
blocks (and of their precursors) from which oligonucleotides derivatized with protected 
maleimides at the 5' end, internal positions, or the 3' end can be obtained, respectively. 
To allow for incorporation of protected maleimides at oligonucleotide positions different from the  
5' end, serinol derivatives containing a protected maleimide on the amine, a DMT group on one 
N
O
O
O CH2CH2OH
H
H
N
O
O
O CH2CH2O
H
H
P
NiPr2
OCNE
N
O
O
O CH2CH2COOH
N
O
O
O CH2CH2CO
H
H
NH
OH
OH
L-serinol
I
II
III
H
H
CNE=2-cyanoethyl; DMT=4,4'-dimethoxytrityl
N
O
O
O CH2CH2CO
H
H
NH
ODMT
O P
NiPr2
OCNE
N
O
O
O CH2CH2CO
H
H
NH
ODMT
O COCH2CH2-CO-NH
Molecules 2015, 20 6395 
 
 
hydroxyl, and either a phosphoramidite or a succinyl group on the other (II and III, respectively, 
Scheme 8) were obtained and successfully used in oligonucleotide synthesis [13]. 
Phosphoramidite I was first coupled to dT10-resin, to yield the corresponding  
(protected maleimido)-oligonucleotide as a single peak after ammonia deprotection. Heating in a MW 
oven (90 min reaction time, see Scheme 9: deprotection conditions A) furnished the target  
maleimido-dT10 in very good yield (>95%). 
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Scheme 9. Two alternatives allow the maleimide moiety to be deprotected, furnishing 
maleimido-oligonucleotides that efficiently react with thiols and provide the target conjugates. 
dT10 is a clean crude-yielding sequence easy to work with in first, proof of principle experiments, 
but not necessarily providing generalizable results. For this purpose, other sequences (10-, 18- and  
21-mer 2'-deoxyoligoribonucleotides with all the nucleobases, and U10) were assembled, derivatized 
with the protected maleimide using amidite I, and the oligonucleotide deprotected and purified. In all 
cases (protected maleimido)-oligonucleotides were satisfactorily obtained and deprotected. 
In order to apply our method in those laboratories where a MW oven is not available, different 
deprotection conditions were tested, which resulted in the conclusion that heating a suspension of 
(protected maleimido)-oligonucleotide in strictly anhydrous toluene for 3–4 h at 90 °C also furnishes 
the target maleimido-oligonucleotide (deprotection conditions B, Scheme 9). We have not found 
significant differences in the crudes when using either of the two deprotection alternatives. Again, the 
amount of oligonucleotide in the suspension was found to be important, and best crudes were obtained 
when the molar amount of oligonucleotide and the volume of toluene employed would furnish a  
25–50 μM concentration were the oligonucleotide soluble in toluene. We have no explanation to the 
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fact that maleimide moieties can be safely deprotected in a MW oven when in a 1:1 MeOH/H2O 
solution, whilst heating the (protected maleimido)-oligonucleotide in slightly humid toluene promotes 
hydrolysis of the maleimide to an unacceptably high degree. 
All the maleimido-oligonucleotides reacted with thiol-containing compounds to provide the target 
conjugates (Scheme 9), thus confirming that the maleimide deprotection conditions do not harm the 
maleimido-oligonucleotide and furnish fully reactive maleimides [10]. 
Very recently [14], it has been reported that (protected maleimido)-oligonucleotides assembled on 
an alkyl-chain-soluble support can successfully be deprotected by heating in toluene (90 min, 90 °C), 
and after solvent removal conjugated with a variety of thiol-containing compounds. Therefore, this 
methodology, routinely used in our laboratory, has also proved successful for others. 
At this point, some comments have to be made in relation to stability issues. Treatments with 
concentrated aqueous ammonia, 0.05 M K2CO3 in MeOH and AMA (1:1 concentrated aqueous 
ammonia/aqueous methylamine mixture) can be used to remove the oligonucleotide permanent 
protecting groups provided that the reaction is carried out at room temperature. Therefore, (protected 
maleimido)-(protected oligonucleotide)-resins have to be assembled using phosphoramidite derivatives 
in which the nucleobases are protected with groups that do not require heating for deprotection,  
such as APac (Pac = phenoxyacetyl), CAc, and GiPrPac or Gdmf (iPrPac = isopropylphenoxyacetyl;  
dmf = dimethylformamidine). (Protected maleimido)-oligonucleotides can be purified and lyophilized 
and safely kept in the freezer for months. They can be kept in aqueous solutions for about one week, 
with no great difference between standing at 15–20 °C or in a refrigerator. Maleimido-oligonucleotides 
are not very stable (see below), so it is highly recommended that maleimide deprotection be 
immediately followed by conjugation. 
Replacement of phosphates by phosphorothioates is a modification that has been extensively used to 
prevent the degradation of potential oligonucleotide drugs by nucleases, in particular 3'-exonucleases. 
One question that troubled us was whether phosphorothioates would react with maleimides and behave 
as thiol competitors in the Michael-type conjugation reactions. Different experiments were carried out 
to address this issue, of which the most important are summarized in Scheme 10 [15]. The conclusion 
was that, in contrast with thiophosphate monoesters, which do react with maleimides, thiophosphate 
diesters do not react with maleimides. On the one hand, the Diels-Alder cycloaddition between  
diene-derivatized phosphorothioate oligonucleotides and maleimide-containing compounds afforded 
the target conjugates with no evidence of multiple incorporation of the maleimide-appending moieties 
onto the oligonucleotide as a result of phosphorothioate-maleimide Michael-type reactions. On the 
other, more challenging experiments with (protected maleimido)-phosphorothioate-modified 
oligonucleotides, where maleimide deprotection was followed by conjugation with a thiol,  
confirmed that even under the heating conditions in which the maleimide is deprotected through  
a retro-Diels-Alder reaction, there is no detectable maleimide-phosphorothioate reaction. 
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Scheme 10. Both diene- and maleimido-derivatized phosphorothioate oligonucleotides can 
be reacted with maleimides and thiols, respectively, and provide the target conjugates with 
no undesired reaction between the thiophosphate diesters and the maleimide. 
3. Further Applications of Protected Maleimides 
3.1. Derivatization of Polyamides. Simultaneous Maleimide Deprotection and Conjugation Allows for 
Double Conjugation of Polyamides as Well as Synthesis of Oligonucleotide Conjugates 
The covalent attachment of different moieties to a biomolecule may serve different goals, such as 
facilitating cell uptake, monitoring the fate of the biomolecule within cells, or allowing biomolecules 
interacting with a given target to be detected and/or captured and identified. The attachment of two 
moieties allows two of these aims to be simultaneously achieved. 
From the synthetic point of view doubly derivatized biomolecules can be prepared in different 
ways, either assembling the conjugate in a stepwise manner employing building blocks that carry the 
desired moieties, or introducing new functional groups into the biomolecule to perform two subsequent 
conjugation reactions in solution, or combining both. With the purpose of carrying out two subsequent 
conjugation reactions in solution, we considered the possibility of exploiting the versatility of 
maleimide protection to attach maleimides and protected maleimides to a biomolecule (or analog). In 
order to broaden the scope of possible applications of protected maleimides, we decided to first 
explore their use in the derivatization of polyamides, in particular peptides, peptide nucleic acids 
(PNAs, oligonucleotide analogs made up of amide-linked N-(2-aminoethyl)glycine units to which 
nucleobases are appended) and peptoids (peptide analogs in which natural amino acids are replaced  
by N-alkylglycines). 
All of these polyamides are commonly assembled by solid-phase synthesis. In the three cases the  
final step that removes permanent protecting groups and cleaves the polyamide-resin linkage is an acid 
treatment with a mixture typically containing at least 90% trifluoroacetic acid in addition to  
scavengers, which does not harm maleimides. However, standard peptide and PNA building blocks 
carry a base-labile Fmoc (9-fluorenylmethoxycarbonyl) temporary protecting group, and the simplest 
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method to elongate peptoid chains on an insoluble matrix consists in the incorporation of chloro- or 
bromoacetyl units, followed by reaction with a large amount of suitably derivatized amines. Both the 
piperidine treatment that removes Fmoc groups and the reaction in which α-haloacyl groups are 
transformed into secondary amines damage maleimides. Hence, free maleimides can only be placed at 
the N-terminal position. 
We hypothesized that maleimides protected with 2,5-dimethylfuran would survive both of these 
basic treatments, and decided to prepare monomers (IV, V and VI) allowing for the introduction of 
protected maleimides into the three types of polyamides (Scheme 11) and use them for their 
derivatization [16]. 
 
Scheme 11. Structures of the monomers that allow protected maleimides to be introduced 
into peptide chains (IV), PNAs (peptide nucleic acids) (V), and peptoids (VI). 
An important issue was assessing that all (protected maleimide)-containing polyamides could be 
deprotected using the previously developed procedures, and eventually identifying best maleimide 
deprotection conditions. MW irradiation of a 1:1 MeOH/H2O solution was found to be the best 
alternative to obtain maleimido-PNAs, whereas heating in toluene is recommended for peptides and 
peptoids. This reaction is troublesome in the case of peptides, since yields are low (30%–50%) and 
prolonging the reaction time results in crudes of increasing complexity. Yet, in all cases, the free 
maleimides that resulted from the retro-Diels-Alder reaction were functional and effectively yielded 
the target conjugates. 
With the aim of increasing the deprotection yield of (protected maleimido)-peptides, we  
examined the possibility of simultaneously carrying out the retro-Diels-Alder reaction and the 
conjugation. When a (protected maleimido)-peptide was heated in the presence of a thiol, we attained a 
global deprotection+conjugation yield higher (80%–95%) than those of the two separated reactions 
(overall 25%–35%). At this point it remained to be seen whether the retro-Diels-Alder reaction that 
removes the maleimide protecting group and the Diels-Alder cycloaddition that allows unprotected 
maleimides to react with 1,3-dienes to afford conjugates could be performed simultaneously. We found 
that this is indeed the case, that these two reactions can be conducted simultaneously because the  
diene-maleimide cycloadduct is more stable than the 2,5-dimethylfuran-maleimide cycloadduct. 
Subsequent experiments have confirmed that protected maleimides appending from peptides are 
difficult to deprotect, and that simultaneous deprotection (by heating in a MW oven) and conjugation 
is the best alternative to synthesize the target conjugate. Formation of the conjugate consumes the free 
maleimide, drives the retro-Diels-Alder equilibrium toward the deprotected maleimide, and prevents 
the maleimide from being degraded. 
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Simultaneous maleimide deprotection and conjugation can also successfully furnish conjugates of 
oligonucleotides and PNAs, as shown in Scheme 12. In the first conjugate, a 12-mer peptide  
(H-CEWYYYEWYYYE-NH2) is attached to an 18-mer 2'-O-methyl, phosphorothioate 
oligoribonucleotide (5'CUUUCCACGCACAGUGCC3', with a triethyleneglycol spacer between the 
oligonucleotide and the protected maleimide). In the second conjugate, a thiol derivative of biotin is 
linked to a 12-mer PNA (H-KK-catagctgtttc-NH2, with two lysines between the N-terminus and the 
protected maleimide to ensure solubility of the PNA chain). In both cases, after the reaction in which 
the oligomer-resin bond was cleaved and the corresponding oligomers were devoid of permanent 
protecting groups, maleimide deprotection and conjugation were carried out simultaneously, and 
satisfactorily afforded the target conjugates. 
 
Scheme 12. Oligonucleotide (A) and PNA (B) conjugates prepared by simultaneously 
carrying out the deprotection of the maleimide and the Michael-type reaction with a thiol. 
As shown in Scheme 13, peptides and PNAs decorated with two different moieties were  
obtained from double conjugations in which a first click reaction (either Diels-Alder or Michael-type) 
with a free maleimide was followed by maleimide deprotection and a second conjugation reaction,  
or in which maleimide deprotection and the second conjugation were simultaneously carried out. 
Cysteine-containing peptides, thiol-derivatized biotin, and diene-oligonucleotides (both with the 
natural phosphates and with thiophosphates) were used as decorating molecules. 
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Hence, the deprotection and conjugation strategy is a suitable alternative to prepare conjugates of 
polyamides (peptides, PNAs, peptoids) and oligonucleotides, as well as to cyclize peptides and 
oligonucleotides (see below). 
 
Scheme 13. Double conjugation on polyamides (peptides, PNAs) incorporating a 
maleimide and a protected maleimide. The free maleimide (shown in red) undergoes a first 
conjugation reaction (Michael-type or Diels-Alder, with a suitably derivatized compound 
here represented by the brown triangle), which is followed by maleimide deprotection and 
a second conjugation with the compound represented by the blue triangle. Maleimide 
deprotection and the second conjugation can be carried out simultaneously (see above). 
3.2. Use of the Maleimide-Thiol Reaction for Cyclization 
Cyclic peptides and cyclic oligonucleotides are interesting molecules because they lack free ends 
and their stability in biological media (in particular to exopeptidases and exonucleases, respectively) is 
higher than that of the linear counterparts, and because cyclization results in structures with a higher 
degree of spatial organization. To our knowledge, when we started this work the thiol-maleimide 
reaction had not been used for the cyclization of oligonucleotides, and only in one occasion to cyclize 
a peptide [17]. 
3.2.1. Cyclic Oligonucleotides 
Our first experiments were carried out with oligonucleotides, which could easily be obtained  
as linear chains after solid-phase synthesis on CPG enabling thiol derivatization, and incorporation  
of a protected maleimide at the 5' end, followed by ammonia deprotection (Scheme 14A;  
oligomer = oligonucleotide) [18]. 
At first there seemed to be no preferred option for the removal of the thiol and maleimide protecting 
groups, and both alternatives were tested. Maleimide deprotection as the first step took place 
satisfactorily. Subsequent removal of the thiol protecting group obviously could not be done by 
reaction with another thiol, since it would react with the maleimide and prevent cyclization. Therefore, 
the oligonucleotide was treated with tris-(2-carboxyethyl)phosphine (TCEP). To our surprise, the 
product resulting from these two reactions, plus incubation at a slightly basic pH to promote 
cyclization, was neither the linear nor the cyclized oligonucleotide, but an oligonucleotide derivatized 
with a thiol and a succinimide. It has been described that maleimides can be reduced to succinimides 
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by reaction with triphenylphosphine in methanol [19], and we infer that the same type of reaction is 
likely responsible for our finding. 
The order of the two deprotection reactions was then reversed. TCEP was employed to deprotect  
the thiol (a thiol could have been used in this case), and subsequently removed, and the resulting 
oligonucleotide was heated to promote the retro-Diels-Alder reaction to afford a fully deprotected 
oligonucleotide (Scheme 14A). However, since both the linear precursor and the cyclic molecule have 
the same mass, we did not know which of these two had been isolated. This question was addressed 
making use of reaction with H2O2 (Scheme 14B), which oxidizes the free thiol on the linear molecule 
to sulfonic acid, and the sulfur of the thiosuccinimide to sulfoxide. These oxidation products can easily 
be differentiated by mass spectrometric analysis, and the conclusion of these experiments was that 
after heating the cyclic oligonucleotide had been obtained. 
 
Scheme 14. Upon heating, oligonucleotides (and peptides, see below) carrying a protected 
maleimide and a free thiol undergo an intramolecular Michael-type reaction that furnishes 
the cyclic compound (A). The linear precursor and the cyclic oligomer can easily be 
distinguished by reaction with hydrogen peroxide and mass spectrometric analysis (B). 
This methodology afforded a variety of cyclic 2'-deoxyoligoribonucleotide sequences, ranging from 
5- to 26-mer. 
3.2.2. Cyclic and Bicyclic Peptides 
For peptide cyclization, peptide-resins incorporating a Trt-protected (Trt = trityl) cysteine  
residue and either a free maleimide (at the N terminus) or a protected maleimide were assembled [20]. 
Trifluoroacetic acid treatment of the maleimido-(protected peptide)-resin afforded the cyclic peptide, 
which meant that in the acidic conditions of the final deprotection reaction the linear precursor  
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had cyclized, as assessed by reaction with H2O2 (see Scheme 14B). Typically, the Michael-type  
thiol-maleimide reaction is carried at slightly basic pH (7.5–8), to favor thiolate addition to the 
electrophile while keeping thiol to disulfide oxidation to a minimum. Hence, this result indicates that 
the reaction can take place even under highly acidic conditions, quite far from conditions commonly 
accepted as optimal. This synthetic alternative has the disadvantage that impurities (20%–25%) 
corresponding to cyclic dimer and trimer are obtained in addition to the target cyclic peptide. 
The acidic deprotection treatment of (protected maleimido)-(protected peptide)-resins was followed 
by heating in a MW oven (25–100 μM 1:1 MeOH/H2O solutions, 90 min, 90 °C). In these cases,  
and keeping the concentration of the solutions within the indicated range during maleimide 
deprotection + cyclization, virtually no undesired dimer and trimer peptides were found (<5%).  
This approach provided cyclic peptides incorporating a variety of trifunctional amino acids (including 
histidine) and ranging from 6- to 12-mer. 
As described above, maleimides and protected maleimides can be attached to peptides to produce 
double conjugates. On the other hand, there is a large set of groups to protect the cysteine side chain 
and be removed under different, orthogonal conditions, which has been exploited to direct the 
regioselective formation of disulfide bridges [21]. Altogether this opened the possibility of combining 
maleimides, protected maleimides and differently protected cysteines to prepare a variety of peptides 
cyclized using the thiol-maleimide Michael-type reaction, such as bicyclic peptides (Scheme 15) and 
cyclic peptides derivatized for conjugation (Scheme 16, Section 3.2.3). Conjugates of similarly 
cyclized peptoids have also been obtained. 
 
Scheme 15. General structures of the bicyclic peptides prepared and the precursor peptide-resins. 
As shown in Scheme 15, the relative positions of the reacting groups, in particular thiols, determine 
the structure of the bicyclic peptides, in which either some peptide residues link two isolated cycles, or 
the two cycles are fused and share amino acids. In any case, chain elongation is followed by the acidic 
deprotection treatment, which provides the first cycle, removal of the StBu group with TCEP and 
purification, and simultaneous maleimide deprotection and cyclization. 
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3.2.3. Conjugates of Cyclic Peptides and Peptoids 
As to the possibility of synthesizing cyclic peptides (or peptoids) incorporating a group that can be 
used for conjugation to another moiety, Scheme 16 shows what their general structure had to be [22]. 
The resin-linked peptide (or peptoid) precursor had to incorporate the two groups that would form the 
cycle plus an additional functionality for conjugation. Again, depending on their relative position the 
group to be used in the subsequent conjugation reaction would append from either one of the 
monomers forming the cycle or from an external residue. 
 
Scheme 16. General structure of the precursors of the cyclic peptide/peptoid derivatized 
for conjugation (the group to be involved in the conjugation reaction is shown in blue), and 
of the resulting conjugates. The additional moiety can be linked to amino acids not forming 
the cycle, either at the C-terminus (A) or at the N-terminus (B) of the peptide chain, or to 
internal residues, both in cycles made up of amino acid (C) and peptoid (D) building blocks. 
The combination of N-terminal maleimide, internal Cys(Trt) and protected maleimide at the  
C-terminus of the resin-linked precursor provided a cycle with an appending protected maleimide, and 
a conjugate with the structure VII (Scheme 16A) after simultaneous maleimide deprotection and  
Diels-Alder conjugation with a 1,3-diene. 
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A precursor with an N-terminal Cys(Fm) (Fm = 9-fluorenylmethyl), an internal Cys(Trt) and a 
protected maleimide at the C-terminus first generated a cycle with an appending protected thiol, from 
which conjugate VIII (Scheme 16B) was obtained after removal of the Fm group with piperidine, 
reduction of the resulting disulfide with TCEP, and reaction with a maleimide-containing compound. 
A cyclic peptide with an internal protected thiol for conjugation was synthesized from a precursor 
containing an N-terminal maleimide, an internal Cys(StBu) and a C-terminal Cys(Trt). In this case the 
cycle obtained after trifluoroacetic acid-mediated deprotection required treatment with TCEP to 
deprotect the internal cysteine, and reaction with a maleimide to yield conjugate IX (Scheme 16C). 
Finally, the cyclic peptoid conjugate X (Scheme 16D) was obtained from a (protected peptoid)-resin 
derivatized at the N-terminus with a protected maleimide, and incorporating an alkyne at an internal 
position and a trityl-protected thiol near the C-terminus. Acidic deprotection followed by MW-promoted 
removal of the maleimide protecting group furnished the cyclic peptoid, and a Cu(I)-catalyzed azide-alkyne 
Huisgen cycloaddition the desired conjugate. 
4. Use of Maleimides for Conjugation: Balance and Perspectives 
Maleimides are highly reactive electrophiles that quickly react with nucleophiles in Michael-type 
reactions, and are also very good dienophiles in Diels-Alder cycloadditions. In the absence of any such 
reagents, they are quite stable in organic solvents, but the range of pH values (5–7) in which they are 
not quickly degraded is fairly small [23]. 
The thiol-maleimide click conjugation reaction has many chemical advantages. It does not require 
catalysts, it is water-compatible, proceeds quickly and cleanly (no side products are generated), and 
very high to quantitative yields can be achieved with no need for adding large excesses of any of the 
reagents. Many maleimide-containing compounds are commercially available, but in case they are not, 
bifunctional compounds incorporating maleimides and carboxyl groups can be easily attached to amines 
forming amide bonds, either in solution or on a solid phase. Hence, the N-terminus of solid-phase 
assembled polyamides (peptide, PNAs and peptoids to mention only the main ones) can easily be 
derivatized, and maleimide protection allows maleimide moieties to be introduced at other positions of the 
polyamide chain as well as to be attached to oligonucleotides. As stated above, maleimido-polyamides 
are very stable, but in the case of oligonucleotides it is much safer to keep the maleimide protected and 
deprotect it immediately before use. In any case, it is recommended that best maleimide deprotection 
conditions are identified in each case. In our hands carrying out maleimide deprotection in the 
presence of maleimide-reacting compounds such as thiols or 1,3-dienes is the best alternative to reduce 
the number and amount of byproducts and increase the overall yield. 
However, the thiol-maleimide Michael-type reaction generates two diastereomers and not a single 
product (Scheme 17), and the resulting thiosuccinimide is not fully stable [24]. It can either undergo 
hydrolysis [25], thiol exchange (through a retro-Michael reaction) [26], or both. 
The thiol-maleimide reaction has been commonly employed to prepare antibody-drug conjugates, in 
particular the two antibody-drug conjugates now approved for the treatment of cancer [2]. In the past 
few years, and for this particular type of conjugates, evidence has been provided showing that the S-C 
bond can be cleaved [27], and that the stability of the thiosuccinimide varies depending on the 
environment [28]. Solvent-accessible linking sites facilitate thiol exchange with plasma thiols, and 
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both accessibility and the charge around the linking site seem to affect imide hydrolysis and/or thiol  
exchange [29]. Once thiosuccinimides are hydrolyzed and succinamic acid derivatives are generated thiol 
exchange no longer takes place [26], therefore the use of maleimide derivatives self-promoting hydrolysis 
of the thiosuccinimide has been proposed as an alternative to stabilize antibody-drug unions [30]. 
 
Scheme 17. The thiol-maleimide reaction generates thiosuccinimides that may revert to 
starting materials, as well as undergo hydrolysis. The resulting thiosuccinamic acids are stable. 
Water-mediated opening of the succinimide ring is an undesired side reaction that leads to a mixture 
of products (succinimide starting material and two succinamic acids, see Scheme 17), but which does 
not cleave the covalent linkage between the two components of the conjugate. Succinimide ring 
opening may also be promoted by non-protonated amines, and has been exploited to attach a new 
group to a previously formed conjugate [14]. 
Concerning thiol exchange, the extent of this process (which involves a retro-Michael reaction 
followed by addition of a new thiol to the transiently formed maleimide) is affected by the pKa of the 
thiosuccinimide-forming thiol [26]. Since thiosuccinamic acids do not undergo thiol exchange, 
hydrolysis of the thiosuccinimide may have a beneficial effect on the stability of the conjugate [31]. 
Cleavage of the carbon-sulfur bond has been observed upon analysis of conjugates by  
electrophoresis [32,33]. The reported results suggest that thiosuccinimides generated from  
N-arylmaleimides are less stable than those obtained from N-alkylmaleimides [32], and are in 
agreement with the literature [34]. Finally, it has also been described that in thiosuccinimides 
generated from N-alkyl-substituted maleimides the longer the alkyl chain the lower the extent of 
hydrolysis [30]. 
Hitherto we have not observed cleavage of the S-C bond, and only on very few occasions hydrolysis 
of the succinimide ring. After the conjugation reaction, the biotin-PNA conjugate here described was 
found to be accompanied by some impurities, one of which was the hydrolysis product, and in a 
previously described experiment we had observed the thiosuccinimide to be highly unstable [16]. 
Curiously, both conjugates have the presence of the biotin moiety in common, but this is likely  
a coincidence. 
The cycloadducts generated from Diels-Alder conjugation reactions also contain succinimide rings. 
So far we have not observed hydrolysis of these succinimide rings, and we are not aware of any report 
disclosing this undesired reaction, which suggests that the stability of succinimides generated from the 
diene-maleimide reaction is higher than that of thiosuccinimides. 
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We also wish to emphasize that the two maleimide-involving conjugation reactions we have worked 
with generate thiosuccinimides and cycloadducts that remain stable under the retro-Diels-Alder 
conditions that we use to deprotect maleimides. Since the reverse Diels-Alder reaction is carried out at 
90 °C, we infer that stability of the two types of succinimides at physiological temperature should not 
be a concern. 
To sum up, the Diels-Alder cycloaddition furnishes fairly stable conjugates, but different 
cycloadducts may also be formed. Reaction times are longer than those needed for the thiol-maleimide 
reaction, and heating may eventually be required. The Michael-type thiol-maleimide reaction is not 
devoid of problems, but it remains a powerful alternative to be taken into consideration, especially in 
experiments not requiring the linkage between the conjugate components to be permanently stable.  
The reaction is quick and efficient, the reagents are easy to use, and many thiol and  
maleimide-containing derivatives are commercially available. In case they are not, many possibilities 
have been described to easily attach maleimides or protected maleimides to the desired molecule. As 
reviewed here, maleimide protection contributes to broaden the scope of alternatives for the 
modification of biomolecules and analogs. 
Finally, a discussion of the advantages and disadvantages of maleimide-involving conjugation 
reactions in which thiols are important players could not be concluded without mentioning that  
different groups are working in the development of thiol-involving reactions that furnish stable 
conjugates [35,36]. 
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